Advancing regulatory science for clinical evidence generation, assessment, and analytics

Active Awarded Last action

Contract number
75F40124A00021
Awardee
Awarding agency
Task orders
5 $72,108,437 obligated

Award facts

Opportunity
  • 75F40124Q00260 Solicitation number
Combined order value
  • $78,332,082 Current, with exercised options
  • $141,917,735 Potential, with all options
Last date to order 74% complete
IDV ceiling 73% used
$98,826,818.32
Maximum order
$98,826,818.32
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Labor Hours

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration established a Blanket Purchase Agreement with International Consulting Associates, Inc. on August 13, 2024, with a ceiling of $98.8 million, set aside for total small business under the GSA Multiple Award Schedule. ICA is an SBA-certified 8(a) minority-owned small disadvantaged business.

The BPA covers advancing regulatory science for clinical evidence generation, assessment, and analytics. Place of performance is Arlington, Virginia. The agreement extends through August 12, 2027.

Recent BPA-call activity reflects substantial customer demand. On September 4, 2024, the FDA issued a $55.7 million labor-hour task order supporting the Center for Devices and Radiological Health (CDRH) for AI-enabled regulatory science and analytics capabilities. On the same date, a $2.1 million firm-fixed-price call advanced CDRH's analytics platform with enterprise querying capabilities, completing September 29, 2026. On June 4, 2025, the FDA issued a $37.3 million modification for a clinical evidence systematic literature review task order and postmarket safety study, extending through June 3, 2030. On September 10, 2025, a $31.4 million firm-fixed-price call to CDRH for advanced data analytics and healthcare IT services was awarded, with completion scheduled for September 18, 2030. These four orders alone total approximately $126 million in funded activity.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00003 $0
Other Administrative Action P00002 · Admin MOD to correct ordering end date in system - advancing regulatory science for clinical evidence generation, assessment, and analytics $0
Other Administrative Action P00001 · Exercise the option I ordering period - advancing regulatory science for clinical evidence generation, assessment, and analytics $0
Original award $0

Quick answers

Who was awarded contract 75F40124A00021?

75F40124A00021 was awarded to International Consulting Associates, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 13, 2024.

How much is contract 75F40124A00021 worth?

Orders under 75F40124A00021 have obligated $72,108,437. Their combined current value, with exercised options, is $78,332,082. Their combined potential value, with all options, is $141,917,735. 75F40124A00021's own ceiling is $98,826,818. A single order can be worth up to $98,826,818.

How many orders have been placed under contract 75F40124A00021?

5 orders have been placed under 75F40124A00021, the latest on September 14, 2026.

Who can order from contract 75F40124A00021?

75F40124A00021 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 75F40124A00021 under another contract?

Yes. 75F40124A00021 is a blanket purchase agreement under 47QTCA23D007W, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40124A00021 competed?

The extent of competition for 75F40124A00021 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV